This inventor holds 1 USPTO granted patent. Top assignee: Sericultural &Agri-Food Research Institute Guangdong Academy of Agricultural Sciences. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: The Innovations of Guang Liu in Triterpenoid Research
Introduction
Guang Liu is a notable inventor based in Guangzhou, China. He has made significant contributions to the field of natural medicines, particularly in the area of glucose and lipid metabolism disorders. His innovative work has the potential to impact diabetes treatment positively.
Latest Patents
Guang Liu holds a patent for the "Preparation and application of triterpenoids with effect of improving glucose and lipid metabolism disorders." This invention relates to a novel triterpenoid compound obtained from L. for the first time. The compound has demonstrated activity in regulating glucose and lipid metabolism, showing enhanced effects when combined with the known triterpenoid compound Momordicoside G. This combination indicates a promising new approach for treating metabolic disorders.
Career Highlights
Guang Liu is affiliated with the Sericultural and Agri-Food Research Institute at the Guangdong Academy of Agricultural Sciences. His research focuses on the development of natural compounds that can aid in the management of metabolic disorders. His work is characterized by a commitment to advancing the understanding of natural medicines.
Collaborations
Guang Liu collaborates with esteemed colleagues, including Mingwei Zhang and Yuanyuan Deng. Their combined expertise enhances the research efforts at the institute, fostering innovation in the field of agricultural sciences.
Conclusion
Guang Liu's contributions to the field of natural medicines through his innovative research on triterpenoids highlight the importance of scientific advancements in improving health outcomes. His work represents a significant step forward in the treatment of glucose and lipid metabolism disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile